Having
been formally trained in science, throughout his career Dr.
Tripodi has interfaced between emerging technologies and their
translation into business opportunities. As a partner with Owen,
Pambianchi & Associates, he has served a variety of biomedical
and biopharmaceutical companies in the areas of technology assessment,
business and technology development strategy and new venture
formation. Prior to this activity, Dr. Tripodi started a successful
consulting company, Tricon Associates, which was merged in 1992
into Owen, Pambianchi. Tricon assisted in the start-up of several
new entities, including Fibritek, for which Dr. Tripodi served
as President and CEO in 1991. Tricon's major focus was to identify
new technology, usually from universities, and position them
either as transfers to existing companies, or as the basis for
new entities. Clients included many academic and research institutions
throughout the country.
Most
of Dr. Tripodi's industrial career was with Johnson &
Johnson. During his approximately 20 years there, he held
various senior positions in R&D, Marketing, Technological
and Strategic Planning at both the divisional and corporate
levels. He was instrumental in establishing several new entities
within Johnson & Johnson and was involved in setting up
the Scripps/J&J collaborative effort, and headed the original
J&J division established to develop technology emanating
from Scripps.
His
career also included positions at Becton-Dickinson, as Director
of Technical Planning, and at New England Nuclear, as General
Manager of the Biomedical Division. He has published extensively
in the fields of immunochemistry and immunology, and holds
several patents, for both drugs and devices.
Since
obtaining his Ph.D. in Immunochemistry from Temple University,
he has continued to maintain academic appointments at Temple
University, University of Pennsylvania and the University
of Delaware. His close ties to the academic, governmental
and industrial communities serve as a valuable perspective
for evaluating new opportunities, and for developing concepts
into actual products and businesses.
He
has served on Scientific Advisory Boards of the State University
of New York at Stony Brook and is currently on the Scientific
Advisory Board of the University of Utah, as well as the Biotechnology
Advisory Committee for the Department of Commerce and the
Immunodiagnostic Committee of the National Committee of Clinical
Laboratory Standards.
Dr.
Tripodi is serving as a Trustee for the Federal Trade Commission
of the Department of Commerce.
